Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,045 | -38,423 | -20,653 | -3,886 | -20,520 |
| Depreciation Amortization | 429 | 219 | 146 | 73 | 387 |
| Accounts receivable | -3,589 | -2,815 | -161 | -974 | 2,441 |
| Accounts payable and accrued liabilities | 594 | 857 | 177 | 911 | -355 |
| Other Working Capital | -4,512 | -6,961 | -5,178 | -2,525 | 1,761 |
| Other Operating Activity | 21,817 | 26,100 | 14,151 | 2,052 | 6,684 |
| Operating Cash Flow | $-34,306 | $-21,023 | $-11,518 | $-4,347 | $-9,602 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -71,883 | -35,028 | 12,781 | 6,601 | -28,257 |
| PPE Investments | -204 | -100 | -41 | -18 | -1 |
| Purchase Sale Intangibles | -139 | -99 | -79 | -19 | -28 |
| Other Investing Activity | -138 | -99 | -79 | -19 | -28 |
| Investing Cash Flow | $-72,226 | $-35,227 | $12,662 | $6,563 | $-28,286 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 632 | 632 | 632 | N/A | N/A |
| Debt Repayment | N/A | -632 | N/A | N/A | N/A |
| Common Stock Issued | 213,487 | 190,943 | 54,184 | 97 | 12,699 |
| Other Financing Activity | -632 | -161 | -180 | 0 | -167 |
| Financing Cash Flow | $213,487 | $190,783 | $54,636 | $97 | $12,532 |
| Beginning Cash Position | 8,997 | 8,997 | 8,997 | 8,997 | 34,353 |
| End Cash Position | 115,952 | 143,529 | 64,776 | 11,309 | 8,997 |
| Net Cash Flow | $106,955 | $134,533 | $55,779 | $2,313 | $-25,356 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,306 | -21,023 | -11,518 | -4,347 | -9,602 |
| Capital Expenditure | -204 | -100 | -41 | -18 | -1 |
| Free Cash Flow | -34,510 | -21,124 | -11,559 | -4,366 | -9,603 |